Imbria Investigational Site — New York, New York

Imbria Investigational Site is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Imbria Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Non-obstructive Hypertrophic Cardiomyopathy.

Sponsors: Imbria Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Imbria Investigational Site?

Imbria Investigational Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Imbria Investigational Site conducted?

Imbria Investigational Site has 1 clinical trials on record. Their work covers Non-obstructive Hypertrophic Cardiomyopathy.

Is Imbria Investigational Site accredited by Crixeo Health?

Imbria Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Imbria Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.